MM-087 Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma

Subjects

Subjects :

Cancer Research
Oncology
Hematology

Details

ISSN :

21522650

Volume :

22

Database :

OpenAIRE

Journal :

Clinical Lymphoma Myeloma and Leukemia

Accession number :

edsair.doi...........65adcde05ae90789089a34985a106763

Full Text :

https://doi.org/10.1016/s2152-2650(22)01591-9